Understanding how natural antibiotics are made
Structural biology of polyether antibiotic biosynthesis
This study is exploring how certain bacteria and yeast make powerful antibiotics that can fight infections and cancer, with the goal of creating new, easier ways to produce these helpful medicines for people who need them.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Urbana-Champaign NIH-funded |
| Lab location | 1 site (Champaign, United States) |
| Project ID | NIH-10918263 on NIH RePORTER |
What this research studies
This research investigates the natural production of polyether antibiotics, which have significant antibacterial, antifungal, and anticancer properties. By studying how these complex molecules are synthesized in living organisms, the research aims to develop engineered bacteria or yeast that can produce these antibiotics more efficiently. This could lead to the creation of new antibiotics that are currently difficult to synthesize. The project involves detailed analysis of the biosynthetic pathways and gene clusters responsible for antibiotic production.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include patients suffering from bacterial infections that are resistant to current antibiotic treatments.
Not a fit: Patients with viral infections or those who do not have antibiotic-resistant infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and effective antibiotics to combat resistant bacterial infections.
How similar studies have performed: Other research has shown success in engineering organisms for antibiotic production, indicating that this approach has potential for breakthroughs in antibiotic development.
Where this research is happening
Champaign, United States
- University of Illinois at Urbana-Champaign — Champaign, United States (Active)
Researchers
- Principal investigator: Kim, Chu-Young — University of Illinois at Urbana-Champaign
- Study coordinator: Kim, Chu-Young
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.